| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.037 | 0.2 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.2 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |